Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2022

MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Upgrades EDI to Include Location Sharing, Shipment Status Improvements

Posted on July 12, 2022 by MissionIR

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing a platform for B2B cross-border shipping in the NAFTA region, announced that it has upgraded its electronic data interchange (“EDI”). The … Continue reading →

Posted in Freight Technologies Inc. FRGT | Leave a comment

Emerging iGaming Technology Trends Fuel Golden Matrix Group Inc.’s (NASDAQ: GMGI) B2B Growth Strategy

Posted on July 12, 2022 by MissionIR

Enhanced graphics, Gamification, AI-powered loyalty systems and data analytics redefining iGaming experience and generating higher player yields for online operators. GMGI sets industry standard, offers 10,000+ games across 25+ providers Company provides highly configurable, modular, white-label, turnkey gaming platforms compatible … Continue reading →

Posted in Golden Matrix Group Inc. GMGI | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Milestone Agreement with DPL Featured in NGT News Article

Posted on July 12, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently signed a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon delivery service partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over a … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Enhances Bioavailability of Orally Administered APIs

Posted on July 12, 2022 by MissionIR

Lexaria is a global innovator in drug delivery platforms The company has developed the patented DehydraTECH(TM) technology that significantly improves the bioavailability of orally administered pharmaceuticals and therapeutics Bioavailability is the fraction of a drug that reaches the site of … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures New Contract from Large Real Estate Investment Trust (REIT)

Posted on July 11, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced its receipt of another new contract for autonomous security robot (ASR) services. The announcement reads, “One of the largest U.S. real estate investment … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Developing ‘Must-Have Application for Consumers and Businesses’

Posted on July 11, 2022 by MissionIR

FingerMotion (NASDAQ: FNGR) is focused on serving the enormous cell phone and reinsurance markets in China through its SMS and MMS, as-yet-unlaunched rich communication services (“RCS”), mobile top-up, and big data services. FingerMotion CEO Martin Shen recently presented at the … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Enters Agreement Putting Cargo Van Program ‘Front and Center for Last Mile Delivery Opportunities’

Posted on July 11, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its entry into a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon Delivery Service Partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004

Posted on July 11, 2022 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited, it has completed the acquisition of a phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Names Former Amazon, Boeing Exec as CFO

Posted on July 11, 2022 by MissionIR

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has announced a new chief financial officer. Former Amazon and Boeing official Elshad Garayev has accepted the new position and will be joining … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Patient Eligibility for Brain Cancer Drug Trial, Receives Approval from U.S. FDA for Protocol Amendment

Posted on July 11, 2022 by MissionIR

Novel brain cancer drug developer CNS Pharmaceuticals, Inc. has received approval from the U.S. FDA for a Protocol Amendment that expands patient eligibility for participation in its potentially pivotal Phase 2 clinical trial for a novel drug candidate that targets … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment